Author

Abdullah Al Zayed

Institution: Qatif Central Hospital

Observed institution: Qatif Central Hospital

ORCID: 0000-0001-8629-7885

Observed ORCID: 0000-0001-8629-7885

OpenAlex ID: A5026823287

Evidence and gaps in clinical outcomes of novel pharmacologic therapies for sickle cell disease: A systematic literature review highlighting insights from clinical trials and real-world studies

2025 · Mohamed Yassin, Caterina Minniti, et al. · Blood Reviews · 13

Position Paper on the Management of Sickle Cell Disease in Saudi Arabia: Understanding Disease Landscape, Identifying Challenges, and Exploring Opportunities in Transfusion Therapies

2025 · Hind AlHumaidan, Abdullah Al Zayed, et al. · Journal of Clinical Medicine · 10

Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease

2023 · Mohammad A. Alshabeeb, Deemah Alwadaani, et al. · Genes · 6

The effect of intermittent fasting on the clinical and hematological parameters of patients with sickle cell disease: A preliminary study

2023 · Khalid Ahmed, Yasamin Abdu, et al. · Frontiers in Medicine · 6

Unraveling the Complex Genomic Interplay of Sickle Cell Disease Among the Saudi Population: A Case-Control GWAS Analysis

2025 · Ali Alghubayshi, Dayanjan Wijesinghe, et al. · International Journal of Molecular Sciences · 5

The use of Eculizumab and Tocilizumab in the treatment of Hyperhemolysis syndrome, a comprehensive literature review

2025 · Ali Aqel, Yousef Al-Asa’d, et al. · Frontiers in Medicine · 4

International expert opinion on challenges and perspectives in sickle cell disease and equitable access to care: place of automated red cell exchanges

2026 · Denise Menezes Brunetta, Luciana Carlos, et al. · Blood Global Hematology

The use of eculizumab and tocilizumab in the treatment of hyperhemolysis syndrome, a literature review

2025 · Ali Aqel, Salam Al-Kindi, et al. · Blood

Works count: 8

Citation count: 41

H-index: 5

I10-index: 1